169 related articles for article (PubMed ID: 2454907)
1. Measurement by leukocyte adherence inhibition of autosensitization of cancer patients to myelin basic protein.
Gouda Z; Thomson DM
Jpn J Cancer Res; 1988 Apr; 79(4):529-37. PubMed ID: 2454907
[TBL] [Abstract][Full Text] [Related]
2. Comparison by leukocyte adherence inhibition of human immune response to cancer-associated immunogens, Thomsen-Friedenreich (T) and Tn, myelin basic protein, and organ-specific cancer neoantigens.
Thomson DM; Springer GF; Desai PR; Scanzano R; Gubersky M; Shenouda G
Clin Immunol Immunopathol; 1988 Nov; 49(2):231-41. PubMed ID: 2458874
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
Thomson DM; Halliday WJ; Phelan K
J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
[TBL] [Abstract][Full Text] [Related]
4. A computerized tube leukocyte adherence inhibition assay to detect antitumor immunity in early human cancer: a review of two years' experience.
Ayeni RO; Tataryn DN; MacFarlane JK; Thomson DM; Schwartz R
Surgery; 1980 Apr; 87(4):380-9. PubMed ID: 6989000
[TBL] [Abstract][Full Text] [Related]
5. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
6. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of tube leukocyte adherence inhibition (LAI) assay for breast, colorectal, stomach and pancreatic cancer.
MacFarlane JK; Thomson DM; Phelan K; Shenouda G; Scanzano R
Cancer; 1982 Mar; 49(6):1185-93. PubMed ID: 7037158
[TBL] [Abstract][Full Text] [Related]
8. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
9. Suppression by serum of immunoreactivity to a common tumour antigen in cancer patients.
Koppi TA; Khan JM; Halliday WJ
Oncology; 1984; 41(2):77-82. PubMed ID: 6200811
[TBL] [Abstract][Full Text] [Related]
10. Selectivity of the micro-leukocyte adherence inhibition assay in pancreatic cancer.
Douglass HO; Russo AJ; Howell JH; Moore MC; Arbuck SG; Chu TM; Goldrosen MH
Cancer; 1979 Mar; 43(3):1084-8. PubMed ID: 371783
[TBL] [Abstract][Full Text] [Related]
11. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
[TBL] [Abstract][Full Text] [Related]
12. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes.
Hong J; Zang YCQ; Li S; Rivera VM; Zhang JZ
Eur J Immunol; 2004 Mar; 34(3):870-881. PubMed ID: 14991617
[TBL] [Abstract][Full Text] [Related]
14. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
Warren KG; Catz I
Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
[TBL] [Abstract][Full Text] [Related]
15. Immunopathogenesis of multiple sclerosis: MBP and beyond.
Meinl E; Hohlfeld R
Clin Exp Immunol; 2002 Jun; 128(3):395-7. PubMed ID: 12067291
[No Abstract] [Full Text] [Related]
16. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity to bovine myelin basic protein in rats bearing malignant fibrous histiocytoma.
Ribeiro RA; Lopes-Alberto F; De-Lucca FL
Braz J Med Biol Res; 1989; 22(6):721-4. PubMed ID: 2482789
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of leukocyte adherence in women with breast cancer using a variety of tissue extracts.
Fritze D; Kaufmann M; Drings P; Fedra G
Oncology; 1978; 35(6):242-5. PubMed ID: 370704
[TBL] [Abstract][Full Text] [Related]
19. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.
Krogsgaard M; Wucherpfennig KW; Cannella B; Hansen BE; Svejgaard A; Pyrdol J; Ditzel H; Raine C; Engberg J; Fugger L
J Exp Med; 2000 Apr; 191(8):1395-412. PubMed ID: 10770805
[TBL] [Abstract][Full Text] [Related]
20. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis.
Vergelli M; Mazzanti B; Traggiai E; Biagioli T; Ballerini C; Parigi A; Konse A; Pellicanò G; Massacesi L
J Neurosci Res; 2001 Nov; 66(3):517-24. PubMed ID: 11746371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
